<?xml version="1.0" encoding="UTF-8"?>
<p id="Par15">Similar to remdesivir, ribavirin functions as an RNA-dependent RNA polymerase inhibitor and is approved for the treatment of RSV and HCV [
 <xref ref-type="bibr" rid="CR37">37</xref>]. Although ribavirin was recommended for COVID-19 treatment according to Chinese guidelines, it lacks solid evidence [
 <xref ref-type="bibr" rid="CR38">38</xref>]. Currently, an open-label randomized controlled trial on lopinavir/ritonavir, ribavirin, and interferon-Î²1b combination vs lopinavir/ritonavir alone is ongoing to evaluate the therapeutic effects on COVID-19 [
 <xref ref-type="bibr" rid="CR25">25</xref>].
</p>
